Annual Operating Profit
-$765.00 K
+$115.00 K+13.07%
31 December 2023
Summary:
XTL Biopharmaceuticals annual operaing income is currently -$765.00 thousand, with the most recent change of +$115.00 thousand (+13.07%) on 31 December 2023. During the last 3 years, it has risen by +$183.00 thousand (+19.30%). XTLB annual operating profit is now -129.79% below its all-time high of $2.57 million, reached on 31 December 2009.XTLB Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$175.00 K
+$25.00 K+12.50%
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly operating income is currently -$175.00 thousand, with the most recent change of +$25.00 thousand (+12.50%) on 31 March 2024. Over the past year, it has dropped by -$24.00 thousand (-15.89%). XTLB quarterly operating profit is now -103.40% below its all-time high of $5.15 million, reached on 31 December 2009.XTLB Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$689.00 K
+$76.00 K+9.93%
31 March 2024
Summary:
XTL Biopharmaceuticals TTM operating income is currently -$689.00 thousand, with the most recent change of +$76.00 thousand (+9.93%) on 31 March 2024. Over the past year, it has increased by +$101.00 thousand (+12.78%). XTLB TTM operating profit is now -116.30% below its all-time high of $4.23 million, reached on 30 June 2010.XTLB TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.1% | -15.9% | +12.8% |
| 3 y3 years | +19.3% | +16.7% | +31.2% |
| 5 y5 years | +3.5% | +12.1% | +15.9% |
XTLB Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +25.8% | -15.9% | +38.8% | at high | +34.3% |
| 5 y | 5 years | at high | +25.8% | -15.9% | +63.1% | at high | +52.9% |
| alltime | all time | -129.8% | +97.0% | -103.4% | +99.3% | -116.3% | +98.0% |
XTL Biopharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$175.00 K(-12.5%) | -$689.00 K(-9.9%) |
| Dec 2023 | -$765.00 K(-13.1%) | -$200.00 K(+32.5%) | -$765.00 K(-3.2%) |
| Sept 2023 | - | -$151.00 K(-7.4%) | -$790.00 K(-6.3%) |
| June 2023 | - | -$163.00 K(-35.1%) | -$843.00 K(-4.4%) |
| Mar 2023 | - | -$251.00 K(+11.6%) | -$882.00 K(+0.2%) |
| Dec 2022 | -$880.00 K(-14.6%) | -$225.00 K(+10.3%) | -$880.00 K(-6.5%) |
| Sept 2022 | - | -$204.00 K(+1.0%) | -$941.00 K(-0.6%) |
| June 2022 | - | -$202.00 K(-18.9%) | -$947.00 K(-9.6%) |
| Mar 2022 | - | -$249.00 K(-12.9%) | -$1.05 M(+1.6%) |
| Dec 2021 | -$1.03 M(+8.8%) | -$286.00 K(+36.2%) | -$1.03 M(+2.9%) |
| Sept 2021 | - | -$210.00 K(-30.7%) | -$1.00 M(-20.9%) |
| June 2021 | - | -$303.00 K(+30.6%) | -$1.27 M(-11.9%) |
| Mar 2021 | - | -$232.00 K(-9.7%) | -$1.44 M(-1.7%) |
| Dec 2020 | -$948.00 K(+12.6%) | -$257.00 K(-45.8%) | -$1.46 M(+0.9%) |
| Sept 2020 | - | -$474.00 K(0.0%) | -$1.45 M(+23.4%) |
| June 2020 | - | -$474.00 K(+84.4%) | -$1.17 M(+30.4%) |
| Mar 2020 | - | -$257.00 K(+5.3%) | -$900.00 K(+6.9%) |
| Dec 2019 | -$842.00 K(+6.2%) | -$244.00 K(+22.6%) | -$842.00 K(+2.8%) |
| Sept 2019 | - | -$199.00 K(-0.5%) | -$819.00 K(+1.1%) |
| June 2019 | - | -$200.00 K(+0.5%) | -$810.00 K(+2.0%) |
| Mar 2019 | - | -$199.00 K(-10.0%) | -$794.00 K(+0.1%) |
| Dec 2018 | -$793.00 K(-36.4%) | -$221.00 K(+16.3%) | -$793.00 K(-7.6%) |
| Sept 2018 | - | -$190.00 K(+3.3%) | -$858.00 K(0.0%) |
| June 2018 | - | -$184.00 K(-7.1%) | -$858.00 K(-23.2%) |
| Mar 2018 | - | -$198.00 K(-30.8%) | -$1.12 M(-10.4%) |
| Dec 2017 | -$1.25 M(-27.3%) | -$286.00 K(+50.5%) | -$1.25 M(-4.5%) |
| Sept 2017 | - | -$190.00 K(-57.1%) | -$1.30 M(-7.8%) |
| June 2017 | - | -$443.00 K(+35.5%) | -$1.42 M(-1.6%) |
| Mar 2017 | - | -$327.00 K(-5.2%) | -$1.44 M(-16.1%) |
| Dec 2016 | -$1.71 M(-14.6%) | -$345.00 K(+15.0%) | -$1.71 M(-19.3%) |
| Sept 2016 | - | -$300.00 K(-35.6%) | -$2.12 M(-4.3%) |
| June 2016 | - | -$466.00 K(-22.6%) | -$2.22 M(-0.7%) |
| Mar 2016 | - | -$602.00 K(-20.2%) | -$2.23 M(+11.3%) |
| Dec 2015 | -$2.01 M(-0.7%) | -$754.00 K(+90.4%) | -$2.01 M(+5.0%) |
| Sept 2015 | - | -$396.00 K(-17.7%) | -$1.91 M(+1.5%) |
| June 2015 | - | -$481.00 K(+27.9%) | -$1.88 M(+4.3%) |
| Mar 2015 | - | -$376.00 K(-42.9%) | -$1.80 M(-10.8%) |
| Dec 2014 | -$2.02 M(+43.3%) | -$658.00 K(+79.3%) | -$2.02 M(+20.3%) |
| Sept 2014 | - | -$367.00 K(-8.9%) | -$1.68 M(+246.6%) |
| June 2014 | - | -$403.00 K(-32.2%) | -$485.00 K(-55.2%) |
| Mar 2014 | - | -$594.00 K(+87.4%) | -$1.08 M(-23.3%) |
| Dec 2013 | -$1.41 M | -$317.00 K(-138.2%) | -$1.41 M(-42.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2013 | - | $829.00 K(-182.9%) | -$2.44 M(-29.0%) |
| June 2013 | - | -$1.00 M(+8.3%) | -$3.43 M(+12.6%) |
| Mar 2013 | - | -$923.00 K(-31.3%) | -$3.05 M(+20.7%) |
| Dec 2012 | -$2.53 M(+106.9%) | -$1.34 M(+713.9%) | -$2.53 M(+66.4%) |
| Sept 2012 | - | -$165.00 K(-73.3%) | -$1.52 M(-7.6%) |
| June 2012 | - | -$617.00 K(+53.9%) | -$1.64 M(+25.5%) |
| Mar 2012 | - | -$401.00 K(+19.7%) | -$1.31 M(+5.4%) |
| Dec 2011 | -$1.22 M(-2.8%) | -$335.00 K(+15.9%) | -$1.24 M(+2.2%) |
| Sept 2011 | - | -$289.00 K(+2.1%) | -$1.21 M(-0.6%) |
| June 2011 | - | -$283.00 K(-15.3%) | -$1.22 M(-2.7%) |
| Mar 2011 | - | -$334.00 K(+8.4%) | -$1.25 M(-0.1%) |
| Dec 2010 | -$1.26 M(-148.9%) | -$308.00 K(+4.1%) | -$1.26 M(-129.9%) |
| Sept 2010 | - | -$296.00 K(-6.6%) | $4.21 M(-0.5%) |
| June 2010 | - | -$317.00 K(-5.4%) | $4.23 M(+26.9%) |
| Mar 2010 | - | -$335.00 K(-106.5%) | $3.33 M(+64.9%) |
| Dec 2009 | $2.57 M(-122.8%) | $5.15 M(-1980.7%) | $2.02 M(-153.1%) |
| Sept 2009 | - | -$274.00 K(-77.4%) | -$3.80 M(-22.2%) |
| June 2009 | - | -$1.21 M(-26.3%) | -$4.89 M(-33.1%) |
| Mar 2009 | - | -$1.65 M(+146.4%) | -$7.30 M(+98.1%) |
| Dec 2008 | -$11.27 M(-56.2%) | -$668.00 K(-50.8%) | -$3.69 M(-87.6%) |
| Sept 2008 | - | -$1.36 M(-62.6%) | -$29.66 M(+5.6%) |
| June 2008 | - | -$3.63 M(-284.3%) | -$28.08 M(-12.4%) |
| Mar 2008 | - | $1.97 M(-107.4%) | -$32.05 M(-5.5%) |
| Dec 2007 | -$25.73 M(+60.4%) | -$26.64 M(<-9900.0%) | -$33.91 M(+43.4%) |
| Sept 2007 | - | $226.00 K(-103.0%) | -$23.65 M(-0.5%) |
| June 2007 | - | -$7.61 M(-6772.8%) | -$23.77 M(+19.3%) |
| Mar 2007 | - | $114.00 K(-100.7%) | -$19.91 M(0.0%) |
| Dec 2006 | -$16.05 M(+27.4%) | -$16.39 M(<-9900.0%) | -$19.91 M(+4.7%) |
| Sept 2006 | - | $114.00 K(-103.0%) | -$19.03 M(+1.0%) |
| June 2006 | - | -$3.75 M(-3393.0%) | -$18.84 M(+6.9%) |
| Mar 2006 | - | $114.00 K(-100.7%) | -$17.63 M(+7.2%) |
| Dec 2005 | -$12.60 M(-24.9%) | -$15.50 M(-5354.2%) | -$16.44 M(-19.0%) |
| Sept 2005 | - | $295.00 K(-111.6%) | -$20.31 M(+2.9%) |
| June 2005 | - | -$2.54 M(-294.8%) | -$19.74 M(-11.3%) |
| Mar 2005 | - | $1.30 M(-106.7%) | -$22.25 M(-1.9%) |
| Dec 2004 | -$16.78 M(+15.2%) | -$19.37 M(-2341.7%) | -$22.69 M(+582.3%) |
| Sept 2004 | - | $864.00 K(-117.1%) | -$3.33 M(-20.6%) |
| June 2004 | - | -$5.05 M(-685.0%) | -$4.19 M(-585.0%) |
| Mar 2004 | - | $864.00 K | $864.00 K |
| Dec 2003 | -$14.56 M(-17.8%) | - | - |
| Dec 2002 | -$17.71 M(+17.1%) | - | - |
| Dec 2001 | -$15.12 M | - | - |
FAQ
- What is XTL Biopharmaceuticals annual operaing income?
- What is the all time high annual operating profit for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual operating profit year-on-year change?
- What is XTL Biopharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly operating profit year-on-year change?
- What is XTL Biopharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals TTM operating profit year-on-year change?
What is XTL Biopharmaceuticals annual operaing income?
The current annual operating profit of XTLB is -$765.00 K
What is the all time high annual operating profit for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual operaing income is $2.57 M
What is XTL Biopharmaceuticals annual operating profit year-on-year change?
Over the past year, XTLB annual operaing income has changed by +$115.00 K (+13.07%)
What is XTL Biopharmaceuticals quarterly operating income?
The current quarterly operating profit of XTLB is -$175.00 K
What is the all time high quarterly operating profit for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly operating income is $5.15 M
What is XTL Biopharmaceuticals quarterly operating profit year-on-year change?
Over the past year, XTLB quarterly operating income has changed by -$24.00 K (-15.89%)
What is XTL Biopharmaceuticals TTM operating income?
The current TTM operating profit of XTLB is -$689.00 K
What is the all time high TTM operating profit for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high TTM operating income is $4.23 M
What is XTL Biopharmaceuticals TTM operating profit year-on-year change?
Over the past year, XTLB TTM operating income has changed by +$101.00 K (+12.78%)